# How to Validate a Predicted Protein Structure: A Workflow for AlphaFold and Other Models

Computational protein structure prediction has advanced to the point where models can rival experimental structures in accuracy for many proteins, yet predicted structures remain hypotheses until validated. This article provides a systematic validation workflow combining per-residue confidence scores, global quality estimates, and stereochemical checks to determine whether a predicted structure is suitable for downstream analyses such as molecular docking, variant interpretation, or mechanistic studies. The workflow applies to AlphaFold predictions and models generated by other structure prediction tools, with clear criteria for when to trust a model, when to apply caution, and when to escalate to experimental structure determination.

## The Validation Problem in Modern Structural Bioinformatics

The gap between known protein sequences and experimentally determined structures remains substantial. Experimental structure determination requires months to years of effort per protein, which explains why only around 100,000 unique proteins have structures despite billions of known sequences. Computational prediction methods have emerged to address this gap, with AlphaFold demonstrating accuracy competitive with experimental structures in a majority of CASP14 assessment cases. The practical consequence is that researchers now routinely generate predicted structures for proteins that have never been experimentally characterized, and these predictions feed directly into downstream research decisions.

Validation is the process of assessing whether a predicted structure is reliable enough for its intended use. A predicted structure with high confidence scores may still contain local errors, and a model with moderate global scores may be perfectly adequate for identifying a binding site or interpreting a disease variant. The validation workflow described here treats structure prediction as a hypothesis-generating tool that requires systematic quality assessment before any biological conclusions are drawn.

The stakes are concrete. A researcher using a poorly validated model for molecular docking may identify false binding poses. A laboratory interpreting disease variants on an unreliable structure may misattribute pathogenic mechanisms. A structural biologist using a predicted complex to design mutagenesis experiments may waste months on experiments based on incorrect interfaces. Validation is not an administrative step but a scientific necessity that determines whether downstream conclusions are defensible.

## Core Principles of Structure Validation

### Confidence Scores Reflect Prediction Certainty, Not Experimental Truth

Prediction methods generate confidence scores that estimate how reliable the model is at each position and overall. These scores are computational estimates based on the neural network's internal assessment, not measurements of physical reality. A high confidence score means the method predicts the structure with high certainty, but this certainty can be wrong, particularly for regions with unusual features or for proteins that do not fold into a single stable conformation.

The per-residue confidence score, commonly called pLDDT in AlphaFold outputs, provides a position-specific estimate of model reliability. Regions with high pLDDT values are generally reliable for structural interpretation, while regions with low values should be treated as unreliable. This distinction matters because a protein may have well-predicted core regions and poorly predicted loop regions within the same model.

### Global Quality Scores Assess Overall Model Reliability

Global quality scores such as QMEAN provide an overall assessment of how well the predicted structure matches expected physicochemical properties of proteins. These scores compare the model against statistical potentials derived from known protein structures, evaluating features such as bond lengths, bond angles, torsion angles, and solvation energy. A model that deviates substantially from these expected properties receives a lower global quality score.

Global scores are useful for comparing alternative models of the same protein and for flagging predictions that are likely to contain substantial errors. However, global scores do not identify which specific regions are problematic, which is why per-residue analysis remains essential.

### Stereochemical Validation Checks Atomic-Level Geometry

Stereochemical validation examines the physical plausibility of the model at the atomic level. Tools such as MolProbity assess bond lengths, bond angles, torsion angles, and atomic clashes to determine whether the model's geometry is consistent with experimentally determined protein structures. Unusual geometry can indicate problems in the prediction, particularly in loop regions or at domain boundaries.

Stereochemical checks are complementary to confidence scores. A model can have high confidence scores yet contain stereochemical problems, or a model with moderate confidence can have excellent geometry. Both types of information are needed for a complete validation assessment.

## At a Glance: Validation Workflow Decision Table

| Validation Stage | Primary Tool or Score | What It Assesses | Action Threshold |
| --- | --- | --- | --- |
| Per-residue confidence | pLDDT from AlphaFold output | Local prediction reliability for each residue | High confidence regions above 90 are suitable for detailed structural interpretation, regions below 50 should be excluded from downstream analysis |
| Global model quality | QMEAN or similar global score | Overall agreement with expected protein properties | Compare against scores for experimentally determined structures, models far outside the expected range require caution |
| Stereochemical geometry | MolProbity or equivalent | Bond geometry, clashes, torsion angles | Ramachandran outliers and severe clashes indicate local model problems that may require refinement or experimental validation |
| Biological plausibility | Manual inspection and literature comparison | Whether the model makes biological sense | If predicted features contradict established experimental data, treat the model with suspicion regardless of computational scores |

## Preparing Input Data for Structure Prediction

### Sequence Quality and Database Selection

The quality of a predicted structure depends on the quality of the input sequence and the depth of the multiple sequence alignment used for prediction. Sequence errors, such as incorrect residue assignments or truncated sequences, propagate directly into the predicted structure. Before running prediction, verify that the input sequence matches the intended protein, including checking for signal peptides, transmembrane regions, and post-translational cleavage sites that may affect the final protein sequence.

The multiple sequence alignment provides evolutionary information that is critical for accurate prediction. Deeper alignments generally support more confident predictions because the method can identify conserved structural features across many related sequences. The NCBI provides sequence databases and search systems that can be used to generate comprehensive multiple sequence alignments for prediction input. Researchers should document which database version and search parameters were used, as these choices affect the resulting alignment and therefore the prediction.

### Handling Isoforms and Sequence Variants

Many proteins exist as multiple isoforms or contain sequence variants that affect structure. The prediction should use the specific sequence relevant to the biological question. For disease variant interpretation, predict the wild-type and variant structures separately and compare them. For isoform-specific questions, predict the isoform of interest instead of a representative sequence.

Sequence length also matters. Very short fragments may not fold into a stable structure on their own, while very long proteins may exceed the practical limits of prediction methods. When working with fragments, consider whether the fragment is likely to adopt the same structure as it does in the full-length protein. The EMBL-EBI training materials provide guidance on selecting appropriate sequence inputs and interpreting prediction outputs for various biological questions.

## Running the Prediction and Generating Initial Outputs

### AlphaFold and AlphaFold-Multimer Workflows

AlphaFold generates predicted structures along with per-residue confidence scores (pLDDT) and predicted aligned error (PAE) values. The pLDDT scores are stored in the B-factor column of the output PDB file, making them accessible to standard structural analysis tools. The PAE matrix provides information about the relative positional error between pairs of residues, which is particularly useful for assessing domain arrangements and multi-domain proteins.

AlphaFold-Multimer extends the method to protein complexes, predicting the structure of multimeric assemblies. The validation of predicted complexes requires additional attention because the interface regions between subunits may have different confidence characteristics than the individual subunits. Research on AlphaFold-Multimer has shown that the method can predict protein interaction interfaces with high sensitivity but limited specificity in some contexts, meaning that not all predicted interfaces are biologically real.

### Alternative Prediction Methods

Other structure prediction methods remain relevant for specific applications. Template-based modeling approaches use known structures of homologous proteins as starting points, which can be valuable when a close homolog exists. Ab initio methods predict structure without templates, which is necessary for proteins with no detectable homologs. The choice of method depends on the protein of interest and the availability of homologous structures.

For transmembrane proteins, specialized topology prediction methods such as TMHMM can provide complementary information about membrane-spanning regions. These methods predict which segments of the protein cross the membrane, information that is valuable for validating whether a predicted structure has a plausible membrane orientation. The accuracy of such topology predictions is well established for transmembrane helices, providing an independent check on predicted structures.

## Per-Residue Confidence Assessment with pLDDT

### Interpreting pLDDT Values

The pLDDT score ranges from 0 to 100, with higher values indicating greater predicted confidence. In practice, regions with pLDDT above 90 are considered highly reliable and suitable for detailed structural interpretation, including side chain analysis and docking studies. Regions with pLDDT between 70 and 90 are generally reliable for backbone structure but may have less accurate side chain conformations. Regions with pLDDT between 50 and 70 are of lower confidence and should be interpreted cautiously. Regions with pLDDT below 50 are unreliable and should not be used for structural conclusions.

These thresholds are practical guidelines instead of absolute rules. A region with moderate pLDDT may still be structurally accurate, and a region with high pLDDT may contain errors. The scores provide a probabilistic assessment that should inform but not replace biological judgment.

### Identifying Disordered Regions and Flexible Loops

Low pLDDT values frequently correspond to intrinsically disordered regions or flexible loops that do not adopt a single stable conformation. For such regions, the predicted structure represents one possible conformation among many, and the specific coordinates should not be overinterpreted. The presence of extended low-confidence regions may indicate that the protein contains disordered segments that are important for function but cannot be accurately modeled.

When a predicted structure contains long disordered regions, consider whether the biological question requires those regions. For questions about the structured core of the protein, the disordered regions can be excluded from analysis. For questions about protein-protein interactions mediated by disordered regions, the predicted structure may be insufficient, and experimental methods such as crosslinking mass spectrometry may be needed to obtain reliable information.

### Using PAE for Domain Arrangement Assessment

The predicted aligned error matrix provides information about the relative positional confidence between residue pairs. Low PAE values between two residues indicate that their relative positions are predicted with high confidence, while high PAE values indicate uncertainty. For multi-domain proteins, the PAE matrix can reveal whether the relative arrangement of domains is confidently predicted or whether the domains could adopt multiple arrangements.

This information is critical for interpreting the overall architecture of the predicted structure. A protein with well-predicted individual domains but poorly predicted domain arrangement requires caution in any analysis that depends on the relative positions of those domains. The PAE matrix should be examined alongside the pLDDT scores to develop a complete picture of prediction confidence.

## Global Quality Assessment with QMEAN and Related Scores

### Computing and Interpreting QMEAN Scores

QMEAN provides a composite score based on several geometric and statistical properties of the model. The score compares the model against expected values derived from experimentally determined structures, with scores near zero indicating good agreement and more negative scores indicating poorer agreement. QMEAN scores are typically reported as Z-scores relative to a reference set of experimental structures, allowing direct comparison between the predicted model and known structures.

A predicted structure with a QMEAN Z-score within the range typical of experimental structures is generally considered reliable. A model with a Z-score far outside this range should be treated with caution, as it suggests the model deviates substantially from expected protein properties. However, QMEAN scores should be interpreted in context, as some proteins naturally have unusual properties that affect their scores.

### Comparing Alternative Models

Global quality scores are particularly useful for comparing alternative models of the same protein. When multiple prediction methods generate different models, or when different parameter settings produce different outputs, QMEAN scores can help identify which model is most likely to be accurate. The model with the best global score is not always the most accurate, but global scores provide a useful first-pass filter.

For comparative purposes, ensure that all models are evaluated with the same scoring method and that the comparison accounts for differences in sequence coverage and model completeness. A model that covers the full protein sequence may score differently than a model that covers only a domain, even if both are accurate for their respective regions.

### Limitations of Global Scores

Global scores summarize the overall quality of the model but do not identify specific problem regions. A model can have an excellent global score while containing a poorly predicted loop that is critical for function. Conversely, a model with a mediocre global score may be perfectly reliable for the specific region of interest. Global scores should be used as a screening tool, with per-residue analysis providing the detailed information needed for biological interpretation.

Global scores also depend on the reference set used for comparison. Scores computed against a reference set of soluble globular proteins may not be appropriate for membrane proteins or proteins with unusual amino acid compositions. When interpreting global scores, consider whether the reference set is appropriate for the protein being evaluated.

## Stereochemical Validation with MolProbity

### Running MolProbity and Interpreting Output

MolProbity assesses the stereochemical quality of a protein structure by examining bond lengths, bond angles, torsion angles, and atomic clashes. The output includes Ramachandran plot statistics, rotamer outliers, clash scores, and other geometric measures. These metrics indicate whether the model's geometry is consistent with experimentally determined protein structures.

For predicted structures, stereochemical validation serves a different purpose than for experimental structures. Experimental structures are refined against diffraction data or other experimental restraints, so stereochemical outliers may indicate refinement problems. Predicted structures are generated by neural networks that may not explicitly enforce all stereochemical constraints, so outliers may indicate regions where the prediction is less reliable.

### Ramachandran Analysis and Rotamer Evaluation

The Ramachandran plot shows the distribution of backbone torsion angles, with most residues falling in favored regions corresponding to common secondary structure elements. Residues in disallowed regions may indicate local prediction errors, although some residues naturally adopt unusual backbone conformations. The percentage of residues in favored and allowed regions provides a summary measure of backbone quality.

Rotamer analysis evaluates the side chain conformations, comparing them against the distribution of conformations observed in experimental structures. Unusual rotamers may indicate errors in side chain placement, which is relevant for analyses that depend on side chain positions, such as docking and interaction studies. However, side chain conformations are often less accurately predicted than backbone conformations, so rotamer outliers should be interpreted with appropriate caution.

### Clash Detection and Correction

Atomic clashes occur when non-bonded atoms are positioned too close together, which is physically unfavorable. Severe clashes indicate local model problems that may require correction before the structure is used for downstream analysis. MolProbity identifies clashes and provides a clash score that summarizes the overall clash situation in the model.

When clashes are detected, consider whether they occur in regions of high or low confidence. Clashes in high-confidence regions may indicate genuine problems with the prediction that warrant further investigation. Clashes in low-confidence regions may simply reflect the uncertainty in those regions and may not be biologically meaningful. In some cases, energy minimization or other refinement procedures can reduce clashes, but refinement should be applied cautiously to avoid introducing new errors.

## Biological Plausibility Assessment

### Comparing Against Known Experimental Data

Computational validation scores provide important information, but they cannot replace comparison against experimental data. If experimental data exist for the protein of interest, compare the predicted structure against those data. Known biochemical properties, such as which residues are essential for function, which regions are post-translationally modified, and which surfaces are involved in interactions, can all be mapped onto the predicted structure to assess plausibility.

For proteins with known homologs, compare the predicted structure against the experimentally determined structures of related proteins. The overall fold should be similar, and functionally important residues should be positioned consistently. Discrepancies between the predicted structure and experimental data for homologs should trigger additional scrutiny.

### Checking for Consistent Biophysical Properties

The predicted structure should have biophysical properties consistent with the protein's known characteristics. A soluble protein should have a hydrophobic core and hydrophilic surface. A membrane protein should have hydrophobic surfaces appropriate for membrane embedding. A protein known to form oligomers should have interfaces that are consistent with the predicted oligomeric state.

These checks are qualitative but can identify obvious problems that computational scores might miss. A predicted structure that places a known phosphorylation site in the protein interior, or that buries a residue known to be essential for binding, is likely to have errors in those regions regardless of confidence scores.

### Evaluating Predicted Complexes

For predicted protein complexes, additional validation considerations apply. The interface between subunits should have favorable physicochemical properties, including complementary shapes and appropriate hydrophobic and hydrophilic contacts. The interface should also be consistent with any experimental data about the interaction, such as mutagenesis results identifying critical interface residues.

Research on AlphaFold-Multimer has demonstrated both the power and the limitations of complex prediction. The method can predict novel interaction interfaces with high confidence, but it also generates false positives, particularly for interactions mediated by short linear motifs in disordered regions. Predicted complexes should be validated against experimental interaction data whenever possible, and the false-positive rate of the predictions should be controlled for before drawing biological conclusions.

## Practical Validation Workflow

### Step 1: Collect and Document Prediction Outputs

Begin by collecting all outputs from the structure prediction run, including the model coordinates, per-residue confidence scores, and any additional output files such as PAE matrices. Document the prediction method, version, parameters, and input sequence used. This documentation is essential for reproducibility and for interpreting the validation results.

Store the prediction outputs in a structured format that allows easy access to all information. The PDB file format stores coordinates and can include confidence scores in the B-factor column. The PAE matrix is typically stored in a separate file. Ensure that all files are associated with the correct sequence and prediction run.

### Step 2: Assess Per-Residue Confidence

Extract the pLDDT scores from the prediction output and map them onto the protein sequence. Identify regions of high confidence, moderate confidence, and low confidence. Determine whether the regions of interest for the biological question fall in high-confidence or low-confidence regions.

For multi-domain proteins, examine the PAE matrix to assess whether the relative domain arrangement is confidently predicted. Identify any domain-domain interfaces with high PAE values, which indicate uncertainty in the relative positions of those domains.

### Step 3: Compute Global Quality Scores

Run global quality assessment tools such as QMEAN on the predicted structure. Record the global score and the Z-score relative to the reference set. Compare the scores against those typical for experimentally determined structures and for other predicted structures of similar proteins.

If alternative models are available, compute global scores for all models and compare them. The model with the best global score is not necessarily the most accurate, but the comparison provides useful information for model selection.

### Step 4: Perform Stereochemical Validation

Run stereochemical validation tools such as MolProbity on the predicted structure. Record the Ramachandran statistics, rotamer outliers, clash score, and other geometric measures. Identify any residues with unusual geometry and determine whether they fall in high-confidence or low-confidence regions.

For residues with severe stereochemical problems in high-confidence regions, consider whether the prediction may have local errors that require correction. For residues with problems in low-confidence regions, the issues may reflect the inherent uncertainty in those regions.

### Step 5: Assess Biological Plausibility

Compare the predicted structure against known experimental data for the protein and its homologs. Map known functional residues, modification sites, and interaction surfaces onto the predicted structure. Check that the overall fold is consistent with expectations and that the biophysical properties are appropriate for the protein's known characteristics.

For predicted complexes, evaluate the interface properties and compare against any experimental interaction data. Consider whether the predicted interface is consistent with known biology and whether the interaction is supported by independent evidence.

### Step 6: Document Validation Results and Decide on Use

Document all validation results in a structured format that records the confidence scores, global quality scores, stereochemical metrics, and biological plausibility assessment. Record any concerns or limitations identified during validation. This documentation should be preserved alongside the predicted structure and should be referenced in any publications or reports that use the structure.

Based on the validation results, decide whether the predicted structure is suitable for the intended downstream analysis. The decision criteria depend on the specific use case. A structure for a docking study requires high confidence in the binding site region. A structure for variant interpretation requires high confidence in the region containing the variant. A structure for understanding overall domain architecture may be adequate even with moderate confidence in some regions.

## Records and Measurements for Validation Tracking

### Maintaining a Validation Log

A validation log provides a systematic record of all validation assessments for each predicted structure. The log should include the prediction method and parameters, the input sequence identifier, the date of prediction, and all validation scores. This log enables comparison across predictions and supports reproducibility.

The validation log should also record any decisions made based on validation results, including whether the structure was used for downstream analysis, whether any regions were excluded from analysis, and whether any refinement was performed. These decisions are important context for interpreting the results of downstream analyses.

### Key Metrics to Record

Record the following metrics for each predicted structure:

- Per-residue confidence scores, including the distribution of pLDDT values and the fraction of residues in each confidence category
- Global quality scores, including the QMEAN score and Z-score
- Stereochemical metrics, including Ramachandran favored and allowed percentages, rotamer outlier percentage, and clash score
- PAE statistics for multi-domain proteins, including the fraction of residue pairs with high predicted error
- Any biological plausibility concerns identified during manual inspection

These metrics provide a quantitative basis for comparing predictions and for communicating validation results to collaborators and reviewers.

### Tracking Validation Across Prediction Updates

Prediction methods are continuously improved, and updated versions may produce different structures for the same protein. When a new prediction is generated, compare the validation metrics against those of previous predictions. Substantial changes in confidence scores or global quality may indicate that the new prediction is more reliable, or they may reflect changes in the prediction method that require re-evaluation.

Maintain version information for both the prediction method and the input data. A prediction generated with an older version of the method and an older version of the sequence database may not be directly comparable to a prediction generated with current versions.

## Common Failure Patterns in Predicted Structures

### Overconfident Predictions in Repetitive Regions

Prediction methods can generate high confidence scores for regions that are actually unreliable, particularly in repetitive sequences or regions with unusual amino acid compositions. Low-complexity regions, coiled-coil regions, and repeat proteins may receive high confidence scores that do not reflect true structural accuracy. These regions should be examined with additional scrutiny even when confidence scores are high.

For repetitive regions, consider whether the predicted structure is consistent with known structural features of such regions. Coiled-coil regions should have the characteristic heptad repeat pattern and hydrophobic core. Repeat proteins should have the expected repeat unit structure. Discrepancies from these expectations may indicate prediction errors.

### Misleading Confidence in Domain Arrangements

The relative arrangement of domains in multi-domain proteins is often predicted with lower confidence than the individual domains themselves. A protein may have well-predicted individual domains but an incorrectly predicted domain arrangement, leading to errors in any analysis that depends on the relative positions of those domains. The PAE matrix is essential for identifying this failure mode.

When the PAE matrix indicates uncertainty in domain arrangement, consider whether the biological question depends on the domain arrangement. If it does, the predicted structure may be insufficient, and experimental methods such as small-angle X-ray scattering or crosslinking mass spectrometry may be needed to determine the domain arrangement.

### False Positive Interfaces in Predicted Complexes

AlphaFold-Multimer and other complex prediction methods can generate interfaces that are not biologically real. Research has shown that the method predicts domain-motif interactions with high sensitivity but limited specificity, meaning that many predicted interfaces are false positives. This is particularly problematic for interactions mediated by short linear motifs in disordered regions.

Predicted complexes should be validated against experimental interaction data whenever possible. Crosslinking mass spectrometry, co-fractionation mass spectrometry, and other experimental methods can provide independent evidence for predicted interactions. The false-positive rate of the predictions should be controlled for before drawing biological conclusions from predicted complexes.

### Stereochemical Problems in Loop Regions

Loop regions are often predicted with lower accuracy than secondary structure elements, and they may contain stereochemical problems such as clashes or unusual torsion angles. These problems may not affect the overall fold but can be important for analyses that depend on loop conformation, such as docking studies or epitope mapping.

When loop regions are important for the biological question, consider whether the predicted loop conformation is reliable. Low confidence scores in loop regions indicate that the specific conformation is uncertain, and the loop may adopt a different conformation in reality. Experimental validation may be needed for loop regions that are critical for function.

## Limitations of Computational Validation

### Validation Scores Are Not Experimental Evidence

Computational validation scores provide estimates of model reliability, but they are not experimental evidence. A predicted structure with excellent validation scores is still a prediction, not a measured structure. The scores indicate that the prediction is likely to be accurate, but they cannot guarantee accuracy, and they cannot detect all possible errors.

For research conclusions that depend critically on the structure, experimental validation may be necessary. Techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance spectroscopy can provide experimental structures that serve as ground truth. Crosslinking mass spectrometry and other lower-resolution methods can provide experimental constraints that validate specific features of predicted structures.

### Method-Specific Limitations

Each prediction method has specific limitations that affect validation. AlphaFold performs best for proteins with deep multiple sequence alignments and may be less accurate for proteins with few homologs. Template-based methods are limited by the availability and quality of templates. Ab initio methods are computationally expensive and may be less accurate for larger proteins.

Understanding the limitations of the specific method used is essential for interpreting validation results. A low confidence score from a method that is known to struggle with a particular protein class may be more concerning than the same score from a method that handles that class well.

### The Challenge of Disordered Regions

Intrinsically disordered regions pose a fundamental challenge for structure prediction and validation. These regions do not adopt a single stable structure, so any predicted structure for them represents one possible conformation among many. Validation scores for disordered regions are typically low, reflecting the genuine uncertainty in their structure.

For proteins with substantial disordered regions, consider whether the biological question requires structural information for those regions. If the question concerns the structured domains, the disordered regions can be excluded from analysis. If the question concerns the disordered regions themselves, computational prediction may be insufficient, and experimental methods that can characterize disordered regions may be needed.

## Safety and Ethical Considerations in Structure Validation

### Responsible Use of Predicted Structures in Research

Predicted structures are powerful tools, but they must be used responsibly. Researchers should clearly communicate the validation status of predicted structures in publications and presentations, including the confidence scores and any limitations identified during validation. Presenting predicted structures as experimentally determined structures is misleading and can lead to incorrect conclusions.

When predicted structures are used for applied purposes, such as drug design or engineering, the validation status should be considered in decision-making. A predicted structure with moderate confidence may be sufficient for initial screening but should not be used for final decisions without experimental validation.

### Data Management and Reproducibility

Reproducibility requires careful data management. Prediction inputs, parameters, and outputs should be preserved and documented. Validation results should be recorded in a structured format that allows others to understand the assessment. The Galaxy Training Network and nf-core documentation provide guidance on reproducible computational workflows that can be applied to structure prediction and validation.

Version control is essential for tracking changes in prediction methods and input data. The Carpentries lessons provide foundational training in version control and reproducible computing practices that are directly applicable to structural bioinformatics workflows.

### Professional Escalation Criteria

When validation results indicate serious problems with a predicted structure, or when the biological conclusions depend critically on structural features that cannot be confidently validated, escalation to experimental methods may be necessary. The following criteria suggest that experimental validation should be considered:

- The predicted structure will be used for high-stakes decisions, such as drug design or clinical variant interpretation
- The biological conclusions depend on structural features in low-confidence regions
- The predicted structure conflicts with established experimental data
- The predicted complex has not been validated by any experimental interaction data
- The protein has unusual features, such as extensive disorder or repetitive regions, that challenge prediction methods

In these cases, consult with structural biologists or experimentalists who can advise on appropriate validation approaches. The NCBI and EMBL-EBI provide resources and training that can help researchers understand the options for experimental structure determination and validation.

## Frequently Asked Questions

### What is the difference between pLDDT and QMEAN scores?

The pLDDT score is a per-residue confidence estimate generated by AlphaFold that indicates how reliable the predicted position of each residue is. QMEAN is a global quality score that assesses the overall agreement of the model with expected physicochemical properties of proteins. The pLDDT score identifies which regions of the model are reliable, while QMEAN provides an overall assessment of model quality. Both scores are needed for a complete validation assessment.

### How should I interpret conflicting validation scores?

Conflicting validation scores are common and require careful interpretation. A model with high pLDDT but poor stereochemistry may have local geometry problems in otherwise well-predicted regions. A model with good global scores but low pLDDT in a functionally important region may be unreliable for questions about that region. When scores conflict, examine the specific regions of interest and consider which score is most relevant to the biological question.

### Can I use a predicted structure for molecular docking studies?

Predicted structures can be used for docking studies, but the validation status of the binding site region is critical. The binding site should be in a high-confidence region with good stereochemistry. If the binding site is in a low-confidence region or contains stereochemical problems, the docking results may be unreliable. Experimental validation of the binding site may be necessary for high-stakes docking applications.

### How do I validate a predicted protein complex?

Validating a predicted complex requires additional steps beyond validating individual subunits. Examine the confidence scores at the interface, assess whether the interface has favorable physicochemical properties, and compare the predicted interface against any experimental interaction data. Research has shown that predicted interfaces can be false positives, so experimental validation of the interaction is important.

### What should I do if my predicted structure has large disordered regions?

Large disordered regions are common in proteins and do not necessarily indicate a problem with the prediction. The disordered regions should be excluded from structural analysis, and the biological question should be refocused on the structured regions. If the disordered regions are functionally important, experimental methods that can characterize disordered regions may be needed.

### How do I know if my predicted structure is accurate enough for variant interpretation?

Variant interpretation requires high confidence in the region containing the variant. The variant position should have a high pLDDT score, and the local structure around the variant should be well-predicted. The predicted effect of the variant should be consistent with known biology and with any experimental data about the variant. If the variant is in a low-confidence region, the predicted structural effect should be treated with caution.

### What are the best resources for learning structure validation?

The EMBL-EBI training portal provides structured learning pathways for structural bioinformatics, including resources on structure prediction and validation. The Galaxy Training Network offers accessible tutorials for computational biology workflows, and the nf-core documentation provides standards for reproducible analysis pipelines. The Carpentries lessons provide foundational training in the computing skills needed for reproducible structural bioinformatics.

### When should I escalate to experimental structure determination?

Escalate to experimental methods when the predicted structure will be used for high-stakes decisions, when the biological conclusions depend on structural features that cannot be confidently validated, or when the predicted structure conflicts with established experimental data. Experimental structure determination is time-consuming and expensive, so escalation should be reserved for cases where computational validation is insufficient for the intended use.

## Related Bioinformatics Guides

- [AlphaFold and Beyond: Predicting Viral Protein Structures for Antiviral Target Discovery](/knowledge/bioinformatics/alphafold-viral-protein-structures-antiviral-targets)
- [Protein Language Models in Bioinformatics: A Practical Guide to Selection and Application](/knowledge/bioinformatics/protein-language-models-in-bioinformatics-a-practical-guide-to-selection-and-application)
- [Structural Comparison and Alignment Algorithms for Protein 3D Structures](/knowledge/bioinformatics/structural-comparison-and-alignment-algorithms-for-protein-3d-structures)
- [AlphaFold and Beyond: Deep Learning for Protein Structure Prediction in Veterinary Virology](/knowledge/bioinformatics/alphafold-deep-learning-protein-structure-prediction-veterinary-virology)
- [How To Use Alphafold To Predict Structure: Structural Analysis and Computational Methodologies in Bioinformatics](/knowledge/bioinformatics/how-to-use-alphafold-to-predict-structure)

## References and Further Reading

- [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/). National Center for Biotechnology Information.
- [EMBL-EBI Training](https://www.ebi.ac.uk/training). European Bioinformatics Institute.
- [Bioconductor](https://bioconductor.org/). Bioconductor Project.
- [Galaxy Training Network](https://training.galaxyproject.org/). Galaxy Project.
- [nf-core Documentation](https://nf-co.re/docs). nf-core.
- [The Carpentries Lessons](https://carpentries.org/lessons). The Carpentries.
- [Highly accurate protein structure prediction with AlphaFold.](https://pubmed.ncbi.nlm.nih.gov/34265844). Nature, 2021.
- [Protein complexes in cells by AI-assisted structural proteomics.](https://pubmed.ncbi.nlm.nih.gov/36815589). Molecular systems biology, 2023.
- [Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation.](https://pubmed.ncbi.nlm.nih.gov/38225382). Molecular systems biology, 2024.
- [Protein structure prediction.](https://pubmed.ncbi.nlm.nih.gov/2126456). Biochimie, 1990.
- [Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.](https://pubmed.ncbi.nlm.nih.gov/11152613). Journal of molecular biology, 2001.

> This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.